Skip to content

Enovis ENOV Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

ESAB logo
ESABESAB
$44.88M+10.4%
AdaptHealth logo
AdaptHealthAHCO
$7.41M+22.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Encompass Health Corporation logo
Encompass Health CorporationEHC
Medtronic logo
MedtronicMDT
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's noncontrolling interests in subsidiaries?
Enovis (ENOV) reported noncontrolling interests in subsidiaries of $2.57M in Q1 2026.
How has Enovis's noncontrolling interests in subsidiaries changed year-over-year?
Enovis's noncontrolling interests in subsidiaries increased by 4.9% year-over-year, from $2.45M to $2.57M.
What is the long-term trend for Enovis's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Enovis's noncontrolling interests in subsidiaries has grown at a -44.9% compound annual growth rate (CAGR), from $44.49M to $2.26M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.